Cargando…

Comparison of Current International Guidelines for the Management of Dyslipidemia

The dyslipidemia guidelines of the three major societies have been revised recently in light of new evidence. LDL-C is the primary target in the ESC, AHA/ACC/Multisociety and Canadian Cardiovascular Society (CCS) guidelines. These guidelines uniformly recommend intensifying lipid-lowering treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aygun, Sevda, Tokgozoglu, Lale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737468/ https://www.ncbi.nlm.nih.gov/pubmed/36498823 http://dx.doi.org/10.3390/jcm11237249

Ejemplares similares

Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Comparison of the current international guidelines on the management of HCC
por: Foerster, Friedrich, et al.
Publicado: (2019)

Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
por: Misra, Sanjana, et al.
Publicado: (2022)

Overview of guidelines for the management of dyslipidemia: EU perspectives
por: Giner-Galvañ, Vicente, et al.
Publicado: (2016)

What do the “new” Pulmonary Hypertension Guidelines tell us: should we change our practice?
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2022 Saudi Guidelines for the Management of Dyslipidemia
por: AlRahimi, Jamilah, et al.
Publicado: (2023)

2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary: Dyslipidemia Guidelines 2015
por: Guerrero, Adriel E.
Publicado: (2016)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020)

A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management
por: Fehér, Csaba, et al.
Publicado: (2016)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

2016 Chinese guidelines for the management of dyslipidemia in adults
Publicado: (2018)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
por: Orringer, Carl E., et al.
Publicado: (2020)

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Publicado: (2016)

Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
por: MacDonald, Blair J., et al.
Publicado: (2023)

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study
por: Ertaş, Fatih Sinan, et al.
Publicado: (2016)

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
por: Carugo, S., et al.
Publicado: (2023)

The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
por: Mirshekari, Mehrzad, et al.
Publicado: (2023)

Reflections from ACC 2015
por: Tokgözoğlu, Lale
Publicado: (2015)

Management of dyslipidemia in children
por: Kalra, Sanjay, et al.
Publicado: (2009)

Contemporary Management of Dyslipidemia
por: Ferraro, Richard A., et al.
Publicado: (2022)

Highlights form ESC 2015
por: Tokgözoğlu, Prof. Lale
Publicado: (2015)

The landscape of preventive cardiology in Turkey: Challenges and successes
por: Tokgozoglu, Lale, et al.
Publicado: (2021)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Dyslipidemia in women: etiology and management
por: Phan, Binh An P, et al.
Publicado: (2014)

Current Options and Future Perspectives in the Treatment of Dyslipidemia
por: Muscoli, Saverio, et al.
Publicado: (2022)

Executive Summary of the 2020 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines
por: Gonzalez-Santos, Lourdes Ella, et al.
Publicado: (2021)

Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
por: Babadagli, Hazal E., et al.
Publicado: (2023)

The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice
por: Lim, Jung Sub
Publicado: (2013)

Highlights from ACC 15 Scientific Sessions: Part 1
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

Highlights from ACC 15 Scientific Sessions: Part 2
por: Kaymaz, Cihangir, et al.
Publicado: (2015)

Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort
por: Yılmaz, Mustafa, et al.
Publicado: (2017)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

Global Trends in the Epidemiology and Management of Dyslipidemia
por: Liu, Tianxiao, et al.
Publicado: (2022)

Screening and Management of Dyslipidemia in Children and Adolescents
por: Schefelker, Juliette M., et al.
Publicado: (2022)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?
por: Calice-Silva, Viviane, et al.
Publicado: (2023)

Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t805liro24uii1tf2it2t8l5r4